Effects of NMDA receptor blockers on cocaine-stimulated locomotor activity in mice

Behavioural Brain Research

Volumn 108, Issue 1, 2000, Pages 57-61

  Uzbay, I Tayfun ^a   Wallis, Cleatus J ^b   Lal, Harbans ^b   Forster, Michael J ^b  

^a Service de rhumatologie   (Turkey)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Cocaine; Locomotor activity; Mice; NMDA receptors

Indexed keywords

COCAINE; DIZOCILPINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COCAINE; DIZOCILPINE MALEATE; DOPAMINE UPTAKE INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0033989471     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00129-1     Document Type: Article

References (33)

1. Berman F.W., Murray T.F. Characterization of [3H] MK-801 binding to N-methyl-D-aspartate receptors in cultured rat cerebellar granule neurons and involvement in glutamate-mediated toxicity. J. Biochem. Toxicol. 11:1996;217-226.
2. Bouyer J.J., Park D.H., Joh T.H., Pickel V.M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminal in rat neostriatum. Brain Res. 302:1984;267-275.
3. Carey R.J., Dai H., Krost M., Huston J.P. The NMDA receptor and cocaine: evidence that MK-801 can induce behavioral sensitization effects. Pharmacol. Biochem. Behav. 51:1995;901-908.
4. Cervo L., Samanin R. Effects of dopaminergic and glutamergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats. Brain Res. 731:1996;31-38.
5. Costall B., Naylor R.J. Bahavioral aspects of dopamine agonists and antagonists. Horn A.S., Korf J., Westerink B.H.C. The Neurobiology of Dopamine. 1979;555-576 Academic Press, London.
6. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
7. Itzhak Y., Stein I. Sensitization to the toxic effects of cocaine in mice is associated with the regulation of N-methyl-D-aspartate receptors in the cortex. J. Pharmacol. Exp. Ther. 262:1992;464-470.
8. Johanson C.-E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:1989;3-52.
9. Karler R., Calder L.D. Excitatory amino acids and the actions of cocaine. Brain Res. 582:1992;143-146.
10. Karler R., Calder L.D., Thai L.H., Bedingfield J.B. A dopaminergic-glutamergic basis for the action of amphetamine and cocaine. Brain Res. 658:1994;8-14.
11. Kely P.H., Seviour P., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:1975;507-522.
12. Kely P.H., Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol. 40:1976;45-56.
13. Kim H.-S., Park W.-K., Jang C.-G., Oh S. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. Brain Res. Bull. 40:1996;201-207.
14. Kim H.-S., Park W.-K. Nitric oxide mediation of cocaine induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. J. Pharmacol. Exp. Ther. 275:1995;551-557.
15. Kim H.-S., Park I.S., Lim H.K., Choi H.S. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in PCPA-treated mice. Arch. Pharm. Res. 22:1999;113-118.
16. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends. Pharmacol. Sci. 13:1992;177-184.
17. Koob G.F. Neural mechanisms of drug reinforcement. Ann. New York Acad. Sci. 654:1992;171-191.
18. Krebs M.O., Desce J.M., Kemel M.L., Gauchy C., Godeheu G., Cheramy A., Glowinski J. Glutamergic control of dopamine release in the rat striatum: evidence for presynaptic NMDA receptors on dopaminergic nerve terminals. J. Neurochem. 56:1991;81-85.
19. Ninan I., Kulkarni S.K. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. Eur. J. Pharmacol. 358:1998;111-116.
20. Ninan I., Kulkarni S.K. Preferential inhibition of dizocilpine-induced hyperlocomotion by olenzapine. Eur. J. Pharmacol. 368:1999;1-7.
21. Phillips A.G., Blaha C.D., Fibiger H.C. Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses. Neurosci. Biobehav. Rev. 13:1989;99-104.
22. Pitts D.K., Marvah J. Neuropharmacology of cocaine: role of monoaminergic systems. Monogr. Neural. Sci. 13:1987;34-54.
23. Pudiak C.M., Bozarth M.A. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci. 53:1993;1517-1524.
24. Pulvirenti L., Swerdlow N.R., Koob G.F. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats. Neurosci. Lett. 103:1989;213-218.
25. Pulvirenti L., Swerdlow N.R., Koob G.F. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav. 40:1991;841-845.
26. Roberts D.C.S., Richardson N.R. Self-administration of psychomotor stimulants using progressive ratio schedules of reinforcement. Boulton A., Baker G., Wu P.H. Animal Models of Drug Addiction - Neuromethods. 24:1992;233-269 Humana Press, Clifton, NJ.
27. Scheel-Kruger J., Braestrup C., Nielson M., Golembiowska K., Mogilnicka E. Cocaine: discussion on the role of dopamine in the biochemical mechanism of action. Ellinwood E.H. Jr, Kilbey M.M. Cocaine and Other Stimulants. 1977;373-408 Plenum, New York.
28. Stolerman I. Drugs of abuse: behavioral principles, methods and terms. Trends Pharmacol. Sci. 13:1992;170-176.
29. Torres G., Rivier C., Weiss F. A ketamine mixture anesthetic inhibits neuroendocrine and behavioral consequences of cocaine administration. Brain Res. 656:1994;33-42.
30. Verma A., Kulkarni S.K. Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology. 107:1992;431-436.
31. Wolf M.E., Xue C.J., White F.J., Dahlin S.L. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Res. 666:1994;223-231.
32. Woolverton W.L., Johnson K.M. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13:1992;193-200.
33. Yamakura T., Mori H., Masaki H., Shimoji K., Mishina M. Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. Neuroreport. 4:1993;687-690.